Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.199 USD | -0.50% |
|
+20.61% | +42.14% |
20/05 | Elite Pharmaceuticals Receives Fda Approval for Generic Methotrexate | CI |
15/02 | Transcript : Elite Pharmaceuticals, Inc., Q3 2024 Earnings Call, Feb 15, 2024 |
- Stock Market
- Equities
- ELTP Stock
- News Elite Pharmaceuticals, Inc.
- Other languages